Miragen Therapeutics Gains $3.0M More

Boulder-based Miragen Therapeutics, a firm focused on discovery and development of therapies for cardiovascular and muscle disease, has raised $3.0M in a convertible note funding, according to a regulatory filing from the firm. Source of the new funding was not disclosed. According to the filing, the firm is in the midst of raising $6.0M. Miragen has previously raised funding from Amgen Ventures, Atlas Venture, Boulder Venturesm, Broadview Ventures, and The Perierls Foundation. The firm is headed by William S. Marshall. More information »